Learn More About GHI Software

New eBook Update: Genetic Data Warehousing – Second Edition

Aug 17, 2020

We’re excited to share the release of a newly updated resource from our CEO, Andreas Scherer, Ph.D. This morning, we published the Second Edition of his eBook, Genetic Data Warehousing, offering an in-depth exploration of how data warehousing technologies are shaping the future of clinical genomics and precision medicine. This…

Read more →

Golden Helix’s NGS-Solutions for Clinical Variant Analysis: VSClinical’s Assessment Catalog

Aug 14, 2020

It doesn’t take much effort to find articles discussing the value of Next-Generation Sequencing (NGS). There is a consistent tone amongst authors that implementing NGS pipelines are critical for clinical efficiency in both hereditary disorders and somatic. However, NGS strategies do not come without their own challenges. Challenges include not…

Read more →

Clinical Variant Analysis for Cancer eBook – Second Edition

May 14, 2020

At Golden Helix, we’re committed to advancing precision oncology through robust software solutions that streamline clinical workflows. As the field of cancer genomics continues to evolve, staying informed about the latest best practices and tools is more important than ever. That’s why we’re excited to announce the release the second…

Read more →

The New ACMG-Based Trio Tutorial

Apr 3, 2020

Our Support Team curates a variety of tutorials to help orient new users to the capabilities of VarSeq. We are happy to announce the team’s new release of the trio tutorial that places emphasis on using the ACMG guidelines. This tutorial gives insight into the proper setup of pedigree structure…

Read more →

Powerful Cohort Analysis with VarSeq’s Count Alleles Algorithm

Feb 25, 2020

Although VarSeq is intentionally designed to be a clinical NGS analysis pipeline tool able to run a handful or even single samples through, we have many users who run large cohort style studies with the tool as well. One common use is to compare case/control data to isolate variants shared…

Read more →

Cyber Security Strategies for NGS Testing Labs: Part IV

Feb 13, 2020

Golden Helix is in a unique position to provide a secure on-premise analysis solution. This capability is based on two enablers. First, we build our software solutions from scratch and from the ground-up with the assumption that it should run on any operating system and potentially behind firewalls or even without internet access. Second, we provide…

Read more →

Cyber Security Strategies for NGS Testing Labs: Part III

Feb 6, 2020

Cyber security threats to organizations are more diverse and dangerous than ever, ranging from curious teenagers testing their skills to insider threats and state-sponsored hackers. On the highest-end, some state-financed actors extend their reach as far as possible into foreign countries. Motivation and intentions might vary, but the outcome for the targeted…

Read more →

Cyber Security Strategies for NGS Testing Labs: Part II

Jan 30, 2020

Data and cyber security breaches are a fact of life. Organizations are aware of the threats and putting their best efforts up to prevent them as much as possible. Industries across the entire spectrum have been exposed in recent years. I will go through a few examples to show how pervasive…

Read more →

Cyber Security Strategies for NGS Testing Labs: Part I

Jan 23, 2020

Hospitals and testing labs are undergoing a digital transformation like any other business in our time. They deal with personal data in categories with the highest level of security requirements: personal identity and medical records. The architecture chosen to store and analyze this data is critical to provide the best…

Read more →

New eBook Release: Cyber Security Strategies for NGS Testing Labs

Jan 9, 2020

We’re excited to kick off the year with the release of our latest eBook, “Cyber Security Strategies for NGS Testing Labs“. As precision medicine continues to transform healthcare through data-driven diagnostics and targeted therapies, it brings with it a new set of challenges—particularly around protecting sensitive genomic data. Traditionally, clinical laboratories and…

Read more →

The New VSClinical ACMG Guidelines Tutorial

Nov 21, 2019

Our tutorials are a popular resource for prospective users. We have added a tutorial to help introduce customers to the ease and utility of the ACMG Guidelines incorporated in VSClinical. The ACMG Guidelines are a collection of 33 criteria that are used to determine a variant’s level of pathogenicity. VSClinical…

Read more →

All New VSClinical AMP Workflow Tutorial

Nov 5, 2019

We have recently added a tutorial to help introduce customers to the ease and utility of the AMP Guidelines incorporated in VarSeq’s VSClinical package. The AMP Guidelines allow users to sort through available clinical evidence in a streamlined fashion to arrive at final classification and interpretation and then transfer that…

Read more →

Variant Interpretation with VSClinical: Evaluation of an X-linked Recessive Mutation

May 21, 2019

Overview VSClinical enables users to evaluate variants according to the ACMG guidelines in a high-throughput fashion and obtain consistent results and accurate variant interpretations. This feature is tightly integrated into our VarSeq platform as well, and when paired together, users can evaluate NGS data and obtain clinical reports all in…

Read more →

VarSeq PhoRank Part: 2 Sample PhoRank Gene Ranking

Dec 18, 2018

The PhoRank tool in VarSeq is further explored in this post by looking at the sample-specific capability. VarSeq PhoRank Part: 1 Variant Phorank Gene Ranking showed how the PhoRank algorithm could be applied to all the variants in a VarSeq project, regardless of the number of (or difference in) samples.…

Read more →

VarSeq PhoRank Part 1: Variant PhoRank Gene Ranking

Dec 13, 2018

One of the main goals of clinical genomics labs is to identify problematic variants in affected individuals. One tool to assist in this search is the phenotype driven variant ontological re-ranking tool in VarSeq called PhoRank. A common situation facing clinicians is sorting through thousands of variants provided by an…

Read more →

NGS-Based Clinical Testing eBook

Feb 16, 2017

This generation of scientists, clinicians and bioinformaticians have already elevated the standards for diagnosis, prediction and care, ultimately improving patient outcome for millions of people by leveraging genomic information. This trend is only going to continue. Next-gen sequencing has made its way into the clinic, and understanding the full scope…

Read more →

NGS-Based Clinical Testing: Part VI

Jan 26, 2017

With a properly defined wet-lab and bioinformatics process, we are able to zero in on clinically relevant variants. How does a lab report on the outcome of their analysis? We find that most laboratories conduct their variant classification based on the guidelines formulated by the American College of Medical Genetics…

Read more →

NGS-Based Clinical Testing: Part V

Sep 20, 2016

Any validated bioinformatics pipeline must be continuously monitored. Quality management in clinical testing labs ensures that any divergence from predefined quality metrics during the analysis of clinical samples is investigated. For example: There is an insufficient number of sequence reads that passed the predefined base quality score threshold The number…

Read more →

NGS-Based Clinical Testing: Part IV

Sep 6, 2016

After the Wet Lab process has been completed, the bioinformatics analysis of the sequencing data work begins. The next three blogs will focus on three aspects of this process. The building blocks of a bioinformatics pipeline, documentation and validation (today’s topic) Quality Management Clinical Reporting The Building Blocks of an NGS…

Read more →

NGS-Based Clinical Testing: Part III

Sep 1, 2016

Getting the NGS wet bench process right is not a small undertaking. Targeted NGS assays such as multigene panels or exome sequencing allow for the targeted analysis of genomic regions that are of particular interest. For every sample type, e.g. blood, formalin-fixed paraffin-embedded specimens, saliva etc, there must be a detailed…

Read more →